The Quigley Corporation

• 1: Home
• 2: About Us
• 3: Business Units
  • 3.1: Cold-EEZE
  • 3.2: Quigley Pharma
  • 3.3: Quigley Manufacturing
• 4: Investor Relations
  • 4.1: Annual Reports
  • 4.2: Review Our SEC Filings
  • 4.3: SEC Form 3, 4, & 5 Reporting
  • 4.4: Investor Kit Request
  • 4.5: Standard & Poor's
• 5: News & Events
  • 5.1: The Quigley Corporation News Releases
    • 5.1.1: Quigley Corporation Archived News
  • 5.2: Quigley Pharma News Releases
    • 5.2.1: Quigley Pharma Archived News Releases
• 6: Contact Us
• 8: Legal
  • 8.1: Privacy Policy

Ted Karkus and Karkus Slate of Directors Seated as Directors of the Quigley Corporation

DOYLESTOWN, Pa., June 15 -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com, today announced that on Friday, June 12, 2009, the United States District Court for the Eastern District of Pennsylvania issued a decision and order rejecting the last of the challenges to the results of the May 20, 2009 shareholder meeting, at which the slate of directors nominated by Ted Karkus was elected to the Board of Directors of the Company.

More...

DOYLESTOWN, PA. – June 12, 2009 – The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com, today announced the resignation of Guy J. Quigley as Chairman, President and Chief Executive Officer of the Company. The resignation is effective immediately, following a proxy contest which culminated on May 20 at the Company’s annual meeting which favored dissident shareholder Ted Karkus and his proposed slate of directors. The Company has accepted the resignation of Charles A. Phillips, COO of The Quigley Corporation and Wendy D. Quigley, Accounting Operations Manager. Mr. Phillips and Ms. Quigley have been with the Company since itsinception in 1989.

More...

The Quigley Corporation Approach

The Company’s approach to product development and marketing is to integrate nature and science to improve human health.

The Quigley Corporation has developed and markets the well-known COLD-EEZE® cold remedy brand, consisting of a proprietary zinc gluconate glycine lozenge and related products for treating the common cold. The Quigley Corporation’s customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. Quigley Manufacturing Inc., manufactures COLD-EEZE and performs other contract manufacturing operations for non-related entities.

Quigley Pharma is a subsidiary involved in the research of various naturally-derived patented compounds with the goal of developing them into ethical pharmaceutical drugs.

Our ongoing objective is to deliver long-term value to our stockholders by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments

Business Units

	Cold-EEZE®More about Cold-EEZE®
	More about Quigley Pharma
	More about QMI